Dean Ellison

A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity

Lutz Müller, Robert J. Mauthe, Christopher M. Riley et al. · Regulatory Toxicology and Pharmacology · 2006 · 454 citations

Biochemistry, Drug Resistance, Medicine +10

Reduction-mediated technetium-99m labeling of monoclonal antibodies.

S J Mather, Dean Ellison · PubMed · 1990 · 168 citations

Immunocytochemical Technique, Applicable Method, Immunology +17

Practical aspects of fast HPLC separations for pharmaceutical process development using monolithic columns

Naijun Wu, Jillian L. Dempsey, Peter Yehl et al. · Analytica Chimica Acta · 2004 · 59 citations

Chemical Engineering, Engineering, Pharmaceutical Process Development +12

A strategic approach to the development of capillary electrophoresis chiral methods for pharmaceutical basic compounds using sulfated cyclodextrins

Lili Zhou, Richard A. Thompson, Sherry Song et al. · Journal of Pharmaceutical and Biomedical Analysis · 2002 · 46 citations

Medicinal Chemistry, Pharmaceutical Science, Engineering +13

Mechanistic study of enantiomeric recognition with native γ-cyclodextrin by capillary electrophoresis, reversed-phase liquid chromatography, nuclear magnetic resonance spectroscopy, electrospray mass spectrometry and circular dichroism techniques

Lili Zhou, Richard A. Thompson, Robert A. Reamer et al. · Journal of Chromatography A · 2003 · 38 citations

Engineering, Capillary Electrophoresis, Medicine +10